3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
49
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Conditions
Sarcoma
1
Primary Myelofibrosis
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Endometrial Neoplasms
1
Interventions
3-Iodobenzylguanidine
2
Cyclophosphamide
2
Gemcitabine
2
Insulin Infusion Systems
2
Powders
2
Suspensions
2
balstilimab
2
leronlimab
2
ruxolitinib
2
talquetamab
2
Abiraterone Acetate
1
Alpelisib
1
Androgen Antagonists
1
Asparaginase
1
Bone Marrow Transplantation
1
Capecitabine
1
Docetaxel
1
Eflornithine
1
HMPL-013
1
Hydrocortisone
1
Immunotherapy, Adoptive
1
LY3023414
1
Magnetic Resonance Spectroscopy
1
Methionine
1
Nivolumab
1
Paclitaxel
1
Peripheral Blood Stem Cell Transplantation
1
Prednisolone
1
Prednisone
1
Proton Pump Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
selinexor
×
1 year
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available